Source: Υπουργείο Υγείας (CY) Revision Year: 2022 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Medofloxine 200 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. White, round, convex film- coated tablets, with diameter of nucleus 9.5 mm. For oral administration. |
Each film-coated tablet contains 200mg of ofloxacin.
Excipient with known effect: lactose.
Each film-coated tablet contains 74 mg lactose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ofloxacin |
Ofloxacin is a quinolone-carboxylic acid derivative with a wide range of antibacterial activity against both Gram-negative and Gram-positive organisms. The primary mode of action of the quinolones is the specific inhibition of bacterial DNA gyrase. This enzyme is required for DNA replication, transcription, repair and recombination. |
| List of Excipients |
|---|
|
Medofloxine also contain croscarmellose sodium, povidone, lactose, microcrystalline cellulose, magnesium stearate, hydroxypropylmethyl cellulose, titanium dioxide (E171) and polyethylene glycol. |
Blisters of polyvinylchloride film and aluminium foil. Blister, with patient information leaflet, in a cardboard carton.
Packs of ten (10) and twenty (20) film-coated tablets are available.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
13357
First authorization: 22/04/1991
Renewal authorization: 15/07/2013
| Drug | Countries | |
|---|---|---|
| MEDOFLOXINE | Cyprus, Estonia |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
